INMED PHARMACEUTICALS INC. Interest Income, Other
INMED PHARMACEUTICALS INC. (INM) reported Interest Income, Other of $136.04 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2023-11-14
- INMED PHARMACEUTICALS INC. interest income, other for the quarter ending 2023-09-30 was $136.04K, a 87.42% increase year-over-year.
- INMED PHARMACEUTICALS INC. interest income, other for the quarter ending 2022-09-30 was $72.59K.
- INMED PHARMACEUTICALS INC. interest income, other for fiscal 2023 was $492.44K, a 412.48% increase from fiscal 2022.
- INMED PHARMACEUTICALS INC. interest income, other for fiscal 2022 was $96.09K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 12 month |
|---|---|---|
| 2023-09-30 | $136.04K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $492.44K 10-K · filed 2023-09-29 | |
| 2022-09-30 | $72.59K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $96.09K 10-K · filed 2023-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |